Parallel Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Parallel Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-47	Closed	-$3.27K	–	3642
2024 Q3	$3.27K	Hold	47	–	–	﹤0.01%	2751
2024 Q2	$3.16K	Buy	47 +21	+81%	+$1.42K	﹤0.01%	2667
2024 Q1	$1.79K	Buy	26 +14	+117%	+$945	﹤0.01%	2839
2023 Q4	$747	Sell	12 -128	-91%	-$7.16K	﹤0.01%	2996
2023 Q3	$7.86K	Buy	140 +60	+75%	+$3.38K	﹤0.01%	2316
2023 Q2	$4.04K	Buy	80 +7	+10%	+$372	﹤0.01%	2505
2023 Q1	$3.98K	Sell	73 -7	-9%	-$409	﹤0.01%	2490
2022 Q4	$5K	Buy	80 +3	+4%	+$199	﹤0.01%	2329
2022 Q3	$5K	Buy	77 +4	+5%	+$276	﹤0.01%	2339
2022 Q2	$4K	Sell	73 -4	-5%	-$219	﹤0.01%	2395
2022 Q1	$5K	Buy	77 +72	+1,440%	+$3.88K	﹤0.01%	2330
2021 Q4	$0	Buy	5 +1	+25%	+$61	﹤0.01%	3336
2021 Q3	$0	Buy	+4	New	+$273	﹤0.01%	3311

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Parallel Advisors's AXNX Position: Q4 2024 in Review

Parallel Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 47 shares — an estimated $3.27K sold.

Parallel Advisors first reported a position in AXNX in Q3 2021 and held it in 13 quarters. The position peaked at $7.86K in Q3 2023. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Parallel Advisors reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Parallel Advisors sold 47 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $3.27K.
Parallel Advisors first reported a position in Axonics, Inc. Common Stock in Q3 2021 and held it in 13 quarters.
Parallel Advisors's Axonics, Inc. Common Stock position peaked at $7.86K in Q3 2023.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.